The nanodrug is engineered to cross this barrier with its payload intact, so drugs that are effective outside the brain may be effective inside as well.

Nano Vivere (ISIN: CN0024013913), a late stage clinical company, pioneering nanomedicine whose technology is based on proprietary technologies and patents, today announced that its biomedical researchers have invented a tiny drug-delivery system that can identify cancer cell types in the brain through “virtual biopsies” and then attack the molecula..

View more at https://www.1888pressrelease.com/nano-vivere-s-nanotechnology-identifies-brain-tumor-types-th-pr-639969.html